142 SANSOME STREET, SAN FRANCISCO, CA
Announces Agreement to be Acquired by Roche
Reports Second Quarter 2025 Financial Results and Corporate Updates
Shareholder votes
Reports First Quarter 2025 Financial Results and Corporate Updates
Annual Report to Security Holders
Investor Presentation
Reports Fourth Quarter and Full Year 2024 Financial Results and Corporate Updates
Changes in Board, Management or Compensation
Q2
Q1
FY 2023
Q3
Notice of Late Filing for Annual Report
Solicitation/Recommendation Statement
Tender Offer Statement by Third Party
Schedule 14D-9C Solicitation/Recommendation Statement Communication
Tender Offer Statement by Issuer
Registration Statement for Securities to be Offered to Employees
Additional Proxy Materials
Definitive Proxy Statement
PRE 14A
Statement of Changes in Beneficial Ownership
Notice of Proposed Sale of Securities
Amended Schedule 14D-9 Solicitation/Recommendation Statement
Amended Tender Offer Statement by Third Party